188 related articles for article (PubMed ID: 23747506)
1. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.
Grabowski N; Hillaireau H; Vergnaud J; Santiago LA; Kerdine-Romer S; Pallardy M; Tsapis N; Fattal E
Int J Pharm; 2013 Oct; 454(2):686-94. PubMed ID: 23747506
[TBL] [Abstract][Full Text] [Related]
2. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles.
Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E
Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338
[TBL] [Abstract][Full Text] [Related]
3. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
[TBL] [Abstract][Full Text] [Related]
4. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.
Mura S; Hillaireau H; Nicolas J; Le Droumaguet B; Gueutin C; Zanna S; Tsapis N; Fattal E
Int J Nanomedicine; 2011; 6():2591-605. PubMed ID: 22114491
[TBL] [Abstract][Full Text] [Related]
5. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
6. Effects of surfactants on the properties of PLGA nanoparticles.
Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
[TBL] [Abstract][Full Text] [Related]
7. Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis.
Platel A; Carpentier R; Becart E; Mordacq G; Betbeder D; Nesslany F
J Appl Toxicol; 2016 Mar; 36(3):434-44. PubMed ID: 26487569
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.
Mura S; Hillaireau H; Nicolas J; Kerdine-Römer S; Le Droumaguet B; Deloménie C; Nicolas V; Pallardy M; Tsapis N; Fattal E
Biomacromolecules; 2011 Nov; 12(11):4136-43. PubMed ID: 21981120
[TBL] [Abstract][Full Text] [Related]
9. Surface-Modified Biodegradable Nanoparticles' Impact on Cytotoxicity and Inflammation Response on a Co-Culture of Lung Epithelial Cells and Human-Like Macrophages.
Grabowski N; Hillaireau H; Vergnaud-Gauduchon J; Nicolas V; Tsapis N; Kerdine-Römer S; Fattal E
J Biomed Nanotechnol; 2016 Jan; 12(1):135-46. PubMed ID: 27301179
[TBL] [Abstract][Full Text] [Related]
10. Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release.
Chhabra R; Grabrucker AM; Veratti P; Belletti D; Boeckers TM; Vandelli MA; Forni F; Tosi G; Ruozi B
Int J Pharm; 2014 Aug; 471(1-2):349-57. PubMed ID: 24882034
[TBL] [Abstract][Full Text] [Related]
11. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
14. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
15. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
[TBL] [Abstract][Full Text] [Related]
16. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
18. Preparation and hydrolytic erosion of differently structured PLGA nanoparticles with chitosan modification.
Ma FK; Li J; Kong M; Liu Y; An Y; Chen XG
Int J Biol Macromol; 2013 Mar; 54():174-9. PubMed ID: 23262384
[TBL] [Abstract][Full Text] [Related]
19. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
